- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-04-0008232

Acrecia Ventures Private Limited
About Acrecia Ventures Private Limited
Data last updated:
Acrecia Ventures Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85300DL2021PTC381642. Its GSTIN is 07AAVCA2748M1ZZ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Meenakshi Bansal and Saurabh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No.163 3rd Floor, Green Valley Pocket 4 – 5 Sector 23 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.75 Cr, a growth of 90% compared to the previous year. For the same year it recorded a net profit of ₹6.65 Lakh (net margin 0.3%) and EBITDA of ₹32.04 Lakh (EBITDA margin 1.5%).
Acrecia Ventures Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0008232).
Company details
Recognitions & Rankings of Acrecia Ventures
Contact details
Acrecia Ventures Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No.163 3rd Floor, Green Valley Pocket 4 – 5 Sector 23 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Acrecia Ventures Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Acrecia Ventures is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Acrecia Ventures Private Limited, buy the company report.
Financials of Acrecia Ventures Private Limited
FY 2024 filings availableAcrecia Ventures Private Limited reported revenue of ₹21.75 Cr (up 90% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 90% in the latest year. EBITDA rose 22% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹21.75 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹32.04 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹6.65 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.5% | ||
| Net Profit Margin | 0.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Acrecia Ventures Private Limited, buy the company report.
Board of directors of Acrecia Ventures Private Limited
Acrecia Ventures has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meenakshi Bansal Also directs: Macred Enterprises LLP, Accrenia Enterprises LLP, H Club Apparels Private Limited and 1 more | Director | 29 May 2021 | 5 Years 5 Months | Current |
| Saurabh Also directs: Mackly Life Science Private Limited | Director | 18 Sep 2024 | 2 Years 2 Months | Current |
Peer comparison
Acrecia Ventures Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gamma Coatings Private Limited | ₹24.36 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| Den Mark Pharmaceuticals Private Limited | ₹23.71 Cr (FY 2024) | 317.0% | Mumbai, Maharashtra, India | |||
| Dueful Healthcare Private Limited | ₹23.56 Cr (FY 2025) | -18.0% | Jaipur, Rajasthan, India | |||
| Bini Laboratories Private Limited | ₹23.43 Cr (FY 2024) | -16.0% | Mumbai, Maharashtra, India | |||
| Shakti Lifescience Private Limited | ₹21.77 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Acrecia Ventures Private Limitedthis company | ₹21.75 Cr (FY 2024) | ₹6.65 Lakh | 0.3% | 90.0% | Delhi, India | |
| Kleenage Products (India) Private Limited | ₹20.22 Cr (FY 2024) | 15.0% | Pune, Maharashtra, India | |||
| Pace Pharmatech Private Limited | ₹19.87 Cr (FY 2025) | 31.0% | Mumbai, Maharashtra, India | |||
| Preetpro Lifesciences Private Limited | ₹19.44 Cr (FY 2025) | 4100.0% | Chandigarh, India | |||
| Nandish Pharma Distributors Private Limited | ₹18.69 Cr (FY 2025) | 10.0% | Mandya, Karnataka, India | |||
| Synbiotics Limited | ₹18.04 Cr (FY 2025) | 4.0% | Padra, Gujarat, India |
To see the full peer comparison of Acrecia Ventures Private Limited, buy the company report.
Auditor
Acrecia Ventures Private Limited is audited by Mehta Garg & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mehta Garg & Associates | FY 2024 | 0027084N |
Shareholding
The shareholding of Acrecia Ventures Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Acrecia Ventures Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Acrecia Ventures Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Acrecia Ventures Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Acrecia Ventures has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAVCA2748M1ZZ | Delhi | Active | 16 Jul 2021 |
To see the full GST registrations and return filing status of Acrecia Ventures Private Limited, buy the company report.
Recent activity
Acrecia Ventures Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Ashish Kumar ceased to be Director on 19 Sep 2024.
Frequently asked questions
Acrecia Ventures is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 May 2021 (5+ years old) and is registered under CIN U85300DL2021PTC381642.
Acrecia Ventures has 2 current directors:
- Meenakshi Bansal - Director
- Saurabh - Director
The latest financial statements of Acrecia Ventures on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Acrecia Ventures is 07AAVCA2748M1ZZ, registered in Delhi.
The CIN (Corporate Identification Number) of Acrecia Ventures is U85300DL2021PTC381642. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acrecia Ventures was incorporated on 29 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Acrecia Ventures by revenue are Gamma Coatings Private Limited, Den Mark Pharmaceuticals Private Limited, Dueful Healthcare Private Limited, Bini Laboratories Private Limited, Shakti Lifescience Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Ashish Kumar ceased to be Director on 19 Sep 2024. Saurabh was appointed as Director on 18 Sep 2024. Rakesh Bansal ceased to be Director on 15 Jan 2024. Acrecia Ventures has 4 board changes on record in total.
Yes, Acrecia Ventures is registered as a small enterprise under Udyam registration (number: UDYAM-DL-04-0008232).
The registered office of Acrecia Ventures is at Unit No.163 3rd Floor, Green Valley Pocket 4 – 5 Sector 23 Rohini, Delhi, India – 110085.
Acrecia Ventures operates in the pharma industry, in the drug formulation and development segment.

